Clinical Trials Browser

Interventional × radium Ra 223 dichloride × Thoracic × Clear all

NCT03996473 2024-10-10

Study to Test the Safety and How Radium-223 Dichloride an Alpha Particle-emitting Radioactive Agent Works in Combination With Pembrolizumab an Immune Checkpoint Inhibitor in Patients With Stage IV Non-small Cell Lung Cancer With Bone Metastases

Phase 1 Terminated

8 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT02283749 2021-02-02

BrUOG L301 With Non-Small Cell Lung Cancer and Bone Metastases

Phase 2 Completed

5 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms